Published October 2000 | Version v1
Report Restricted

Glioblastoma, gadolinium (III) and NCT. An in vitro study

  • 1. CNR, Institute of Neurobiology and Institute of Cell Biology, Roma (Italy)
  • 2. ENEA, Radiobiology Dept., Roma (Italy)
  • 3. UCSC, Institute of Neurosurgery, Rome (Italy)
  • 4. Univ. of Wisconsin-Madison, WI (United States)

Description

We treated cultured human glioblastoma cells with gadolinium (III) [gadopentetic acid] and we found that: a) cells do internalise this element; b) gadolinium can be localised in the cells nuclei; c) exposure of the cultures to a neutron beam produced a significant and immediate cell death. Although cell survival was also influenced in the irradiated controls it was further reduced (about 50%) in cells pre-exposed to 10 mg/ml gadopentetic acid. We also found that Gd uptake, as measured by ICP-AES, was concentration dependent. (author)

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Part of:
Proceedings of the ninth international symposium on neutron capture therapy for cancer

Additional details

Publishing Information

Imprint Title
Proceedings of the ninth international symposium on neutron capture therapy for cancer
Imprint Pagination
369 p.
Journal Page Range
p. 219-220
Report number
KURRI-KR--54

Conference

Title
9. international symposium on neutron capture therapy for cancer
Dates
2-6 Oct 2000
Place
Osaka (Japan)

Optional Information

Notes
10 refs., 3 figs.